Summary
Rheumatoid arthritis-associated amyloidosis, though decreasing, causes significant illness and death. Treating rheumatoid arthritis lowers serum amyloid A (SAA) levels, preventing and treating this amyloidosis, especially kidney complications.
Area of Science:
- Immunology
- Nephrology
- Rheumatology
Background:
- Amyloidosis associated with rheumatoid arthritis (RA) leads to increased morbidity and mortality.
- AA amyloid fibrils, derived from serum amyloid A (SAA), are linked to rheumatoid disorders.
- Elevated SAA levels are a prerequisite for developing AA amyloidosis.
Purpose of the Study:
- To highlight the significance of amyloidosis in rheumatoid arthritis.
- To emphasize the role of SAA in AA amyloid formation.
- To recommend treatment strategies for managing RA-associated amyloidosis.
Main Methods:
- Literature review on reactive amyloidosis in rheumatoid arthritis.
- Analysis of the precursor protein (SAA) in amyloid fibril formation.
- Evaluation of treatment outcomes for rheumatoid arthritis and amyloidosis.
Main Results:
- AA amyloidosis remains a critical complication of rheumatoid arthritis, despite a potential decrease in incidence.
- Serum amyloid A (SAA) is the precursor to AA amyloid fibrils.
- Effective management of rheumatoid arthritis reduces SAA levels, offering prophylactic and therapeutic benefits.
Conclusions:
- Treating the underlying rheumatoid arthritis is crucial for preventing and managing AA amyloidosis.
- Lowering SAA levels through RA treatment is a key therapeutic strategy.
- Renal disease is a severe complication, necessitating consideration of dialysis and transplantation.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...